U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274579) titled 'An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma' on Nov. 27.
Brief Summary: We plan to develop a deep learning-based automatic interpretation model for CLDN18.2 using our institution's and multiple other centers' extensive pathological resources of digestive system adenocarcinomas. This study will not only strictly follow the latest domestic expert consensus and standards, but also aims to address current pain points in manual interpretation. It seeks to provide technical support for standardizing, objectifying, and streamlining CLDN18.2 testing, thereby advancing the applicatio...